1 조기호, "동서의학 진료 가이드 북" 고려의학 15-32, 2001
2 조기호, "뇌졸중발증초기환자에 대한 양격산화탕의 유효성의 검토" 일본동양의학잡지 53 (53): 199-, 2002
3 최동준, "급성기 중풍환자에 대한 성향정기산의 임상적 효능" 23 (23): 440-446, 2002
4 Scott GN, "Update on natural product-drug interactions" 59 : 339-347, 2002
5 Toth C, "The use of a bolus of intravenous heparin while initiating heparin therapy in anticoagulation following transient ischemic attack or stroke does not lead to increased morbidity or mortality" 14 (14): 463-468, 2003
6 Janetzky K,, "Probable interactions between warfarin and ginseng" 54 : 692-693, 1997
7 Page RL, "Potentiation of wafarin by dong quai" 19 : 870-876, 1999
8 Zhu M,, "Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats" 51 : 175-, 1999
9 Jones CB, "Levofloxacin and warfarin interaction" 36 (36): 1554-1557, 2002
10 Vaes LP,, "Interactions of warfarin with garlic ginger, ginkgo, or ginseng: nature of the evidence." 34 : 1478-1482, 2000
1 조기호, "동서의학 진료 가이드 북" 고려의학 15-32, 2001
2 조기호, "뇌졸중발증초기환자에 대한 양격산화탕의 유효성의 검토" 일본동양의학잡지 53 (53): 199-, 2002
3 최동준, "급성기 중풍환자에 대한 성향정기산의 임상적 효능" 23 (23): 440-446, 2002
4 Scott GN, "Update on natural product-drug interactions" 59 : 339-347, 2002
5 Toth C, "The use of a bolus of intravenous heparin while initiating heparin therapy in anticoagulation following transient ischemic attack or stroke does not lead to increased morbidity or mortality" 14 (14): 463-468, 2003
6 Janetzky K,, "Probable interactions between warfarin and ginseng" 54 : 692-693, 1997
7 Page RL, "Potentiation of wafarin by dong quai" 19 : 870-876, 1999
8 Zhu M,, "Possible influences of ginseng on the pharmacokinetics and pharmacodynamics of warfarin in rats" 51 : 175-, 1999
9 Jones CB, "Levofloxacin and warfarin interaction" 36 (36): 1554-1557, 2002
10 Vaes LP,, "Interactions of warfarin with garlic ginger, ginkgo, or ginseng: nature of the evidence." 34 : 1478-1482, 2000
11 Leon PJ Vaes, "Interactions of Warfarin with Garlic,Ginger, Ginkgo, or Ginseng: Nature of the Evidence." 34 : 1478-1482, 2000
12 Chan TY, "Interaction between warfarin and danshen(Salvia miltiorrhiza)." 35 : 501-503, 2001
13 Katoh M,, "Inhibition of human cytochrome P450 enzymes by 1,4-dihydropyridine calcium antagonists: prediction of in vivo drug-drug interactions." 55 (55): 843-852, 2000
14 Kuhn MA, "Herbal remedies: drug-herb interactions" Daemen Collage 22 (22): 22-8, 2002
15 Adriane Fugh-Berman, "Herb-drug interactions: Review and assessment of report reliability" Blackwell Science Ltd Br J Clin Pharmacol 2001;52 52 : 587-595, 2001
16 Stoysich AM,, "Further elucidation of pharmacokinetic interaction between diltiazem and warfarin" 34 (34): 56-60, 1996
17 Yamreudeewong W,, "Effect of levofloxacin coadministration on the international normalized ratios during warfarin therapy" 23 (23): 333-338, 2003
18 Stephen LJ, "Drug treatment of epilepsy in elderly people focus on valproic acid" 20 (20): 141-152, 2003
19 Wittkowsky AK, "Drug interactions update: drugs, herbs, and oral anticoagulation" 12 (12): 67-71, 2001
20 Harder S,, "Clinically important drug interactions with anticoagulants.An update" 30 (30): 416-444, 1996
21 Matthews MK Jr, "Association of Ginkgo biloba with intracerebral hemorrhage" 50 : 1933-1934, 1998
22 Trujillo TC, "Antiarrhythmic agents: drug interactions of clinical significance" 23 (23): 509-532, 2000
23 "ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation" 104 : 2118-2150, 2001